Skip to content

Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02092558
Enrollment
2
Registered
2014-03-20
Start date
2005-01-31
Completion date
2013-12-31
Last updated
2014-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Night Wetting and Day Wetting, Menstruation's Disorders, Urolithiasis, Defects of Urinary, System and Hematuria., The Follow-up Duration Was 1-8 Years., The Main Reasons Behind Visiting the Hospital Were Recurrent Urinary Tract Infection,, Urinary Urgencies, Pollakiuria, Difficulty in Initiating Micturition, Pain in Hypogastrium,

Keywords

metaplasia, dysfunction, urinary bladder, children

Brief summary

Background: Squamous metaplasia refers to the pathological transformation of the urothelium leading to non-keratinised stratified squamous metaplasia (N-KSM). Objective: To present the investigators experiences in the diagnosis and treatment of N-KSM of the urinary bladder in children.

Detailed description

Design, setting, and participants: In this study, the investigators present their experiences in the diagnosis and treatment of N-KSM of the urinary bladder in children aged from 5 to 17 years. From 2005 to 2013, metaplasia was diagnosed in 119 patients - 116 girls and 3 boys. The reasons behind visiting the hospital were non-specific intense pain in the abdomen, recurrent urinary tract infections, and urination disorders. The most common symptoms of urinary bladder dysfunction were pollakiuria and difficulties in initiating micturition and retention of urine (reduced detrusor muscle activity). Outcome measurements and statistical analysis: In 20 patients (16.8%), metaplasia was incidentally diagnosed during cystoscopy performed for other causes. Only the children whose bladders showed metaplastic changes on cystoscopy were subjected to a bladder biopsy for collecting specimens for further histopathological examination.

Interventions

DRUGSecond-generation cephalosporin, nitrofurantoin, 1% aminoglycoside solution
DRUGcephalosporin with chemotherapeutics

Second-generation cephalosporin was prescribed for 10 days, and then treatment crossover with chemotherapeutics in therapeutic dose (change in every week) during 3 months

Sponsors

Children's Hospital, Dziekanów Leśny, Poland
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* The follow-up duration was 1-8 years. * The main reasons behind visiting the hospital were: 1. recurrent urinary tract infection, 2. urinary urgencies, 3. pollakiuria, 4. difficulty in initiating micturition, 5. pain in hypogastrium, 6. night wetting and day wetting, 7. menstruation's disorders, 8. urolithiasis, 9. defects of urinary system and hematuria.

Exclusion criteria

* No confirmation of squamous metaplasia of the urinary bladder in diagnostic cystoscopy

Design outcomes

Primary

MeasureTime frame
Symptoms of stratified squamous metaplasia of urinary bladder and treatment's ways5 years

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026